GT enters the back half of August with a familiar tension: short sellers are trimming positions yet the stock continues to fall, suggesting the pressure is coming from somewhere other than the bears.
The short interest picture is genuinely notable here. At 12.6% of free float, GT carries one of the heavier short burdens in the auto-parts universe — and that figure has been drifting lower all week, down nearly 6% over seven days to roughly 36 million shares. That partial retreat is meaningful context. Earlier this month, shorts ran as high as 38.3 million shares before pulling back sharply around August 10, likely as traders covered ahead of the Q2 print on August 6. The borrow market remains relaxed throughout: cost to borrow is running at just 0.49%, and availability sits at 360% — meaning there are more than three shares available to lend for every one currently borrowed. That combination of high short interest, easing positions, and loose borrow conditions does not point to a squeeze setup. It points to cautious bears taking some profit while leaving a substantial residual bet in place.
Options positioning reinforces the picture of a market that isn't particularly excited about the stock in either direction. The put/call ratio at 0.81 is fractionally below its 20-day average of 0.82 — a mild z-score of -1.6 — which means options traders are actually marginally less hedged than they've been recently. That's a quiet signal: neither aggressive bearishness nor fresh bullish conviction. The PCR has been remarkably stable for nearly a month, barely moving from an 0.82 band that has persisted since late July.
The Street remains divided and cautious on valuation. The most recent analyst action was JP Morgan's Rajat Gupta lifting his target from $9 to $10 on August 7, maintaining Overweight — but that note now looks strained against a stock trading at $5.93, which implies roughly 69% upside to his target. Deutsche Bank downgraded to Hold back in May. Citigroup sits at Neutral with an $8 target. Morgan Stanley remains Underweight. The consensus mean target of $7.46 implies meaningful upside from current levels, but the stock has been a serial disappointment against those targets all year. On valuation, the price-to-book at 0.57 reflects a market pricing in ongoing distress, and the EV/EBITDA of 5.3x is undemanding — but only if earnings prove sustainable. The PE of 98.7x, bloated by slim earnings, is less reassuring. EPS momentum factor scores rank in the bottom decile on both 30-day and 90-day measures, though the earnings surprise rank at the 81st percentile suggests the company has consistently outperformed depressed expectations.
Recent earnings history reinforces why the stock remains under pressure. The Q2 print on August 6 sent shares down nearly 6% on the day and a further 16% over the following five days — the kind of reaction that builds scar tissue in a holder base. That decline is what drove the 18.7% one-month drop in GT shares. The week's 2.6% slide arrives in company: close peer LCII fell 3.8% on the week, and ALV dropped 1.7%, suggesting auto-parts names broadly are carrying macro headwinds rather than GT facing company-specific selling pressure alone.
BlackRock's latest reported position — 36.2 million shares, or 12.6% of the company — is almost exactly equal to the entire estimated short interest, an institutional concentration that adds a layer of potential technical support if sentiment shifts. The ORTEX short score at 58.7 has been essentially flat for two weeks, confirming no dramatic directional move in the short-side story. The next catalyst is the November 6 earnings date, and how the gap between the $7.46 consensus target and the current $5.93 price evolves between now and then is the number worth tracking.
See the live data behind this article on ORTEX.
Open GT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
